id: poole2017_coffee
title: 'Coffee consumption and health: umbrella review of meta-analyses'
authors:
- Poole R
- Kennedy OJ
- Roderick P
year: 2017
reference_type: Meta-analysis
keywords:
- coffee
- mortality
- cardiovascular
- cancer
- depression
- meta-analysis
- longevity
- caffeine
hard_claims:
- summary: "Coffee consumption (3-4 cups/day) associated with 17% reduced all-cause mortality"
  choice: coffee
  evidence_type: Meta-analysis
  effect_size: 0.83
  effect_ci_lower: 0.79
  effect_ci_upper: 0.88
  outcome: "all-cause mortality"
  population: "general adult population"
  sample_size: null
  followup_years: null
  notes: "Umbrella review of 201 meta-analyses; optimal consumption 3-4 cups/day"
- summary: "Coffee consumption associated with 19% reduced cardiovascular mortality"
  choice: coffee
  evidence_type: Meta-analysis
  effect_size: 0.81
  effect_ci_lower: 0.72
  effect_ci_upper: 0.90
  outcome: "cardiovascular mortality"
  population: "general adult population"
  sample_size: null
  followup_years: null
  notes: "At optimal intake of 3-4 cups/day"
- summary: "Coffee consumption associated with 18% reduced cancer incidence"
  choice: coffee
  evidence_type: Meta-analysis
  effect_size: 0.82
  effect_ci_lower: 0.74
  effect_ci_upper: 0.89
  outcome: "cancer incidence"
  population: "general adult population"
  sample_size: null
  followup_years: null
  notes: "High vs low coffee consumption"
soft_claims: []
journal: BMJ
volume: '359'
issue: ''
pages: j5024
doi: 10.1136/bmj.j5024
pmid: '29167102'
url: https://pubmed.ncbi.nlm.nih.gov/29167102/
summary: 'Umbrella review synthesizing 201 meta-analyses on coffee consumption and health. Found optimal benefits at 3-4 cups/day with 17% reduced all-cause mortality (RR 0.83), 19% reduced cardiovascular mortality (RR 0.81), and 18% reduced cancer incidence (RR 0.82). Coffee generally safe within usual intake levels except during pregnancy.'
